share_log

Insider Spends US$301k Buying More Shares In PetMed Express

Insider Spends US$301k Buying More Shares In PetMed Express

内幕人士花费30.1万美元购买更多PetMed Express股票
Simply Wall St ·  2023/11/15 05:31

Investors who take an interest in PetMed Express, Inc. (NASDAQ:PETS) should definitely note that the Independent Chairman of the Board, Gian Fulgoni, recently paid US$7.34 per share to buy US$301k worth of the stock. That certainly has us anticipating the best, especially since they thusly increased their own holding by 60%, potentially signalling some real optimism.

对PetMed Express, Inc.(纳斯达克股票代码:PETS)感兴趣的投资者一定要注意,独立董事会主席吉安·富尔戈尼最近以每股7.34美元购买了价值30.1万美元的股票。这无疑让我们对最好的表现进行了期待,尤其是因为他们因此将自己的持股量增加了60%,这可能预示着一些真正的乐观情绪。

View our latest analysis for PetMed Express

查看我们对PetMed Express的最新分析

PetMed Express Insider Transactions Over The Last Year

PetMed Express 过去一年的内幕交易

Notably, that recent purchase by Gian Fulgoni is the biggest insider purchase of PetMed Express shares that we've seen in the last year. That means that an insider was happy to buy shares at around the current price of US$7.90. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. In this case we're pleased to report that the insider purchases were made at close to current prices.

值得注意的是,吉安·富尔戈尼最近的收购是我们去年见过的最大规模的内幕收购PetMed Express股票。这意味着内部人士乐于以当前7.90美元左右的价格购买股票。尽管自收购以来,他们的看法可能已经改变,但这至少表明他们对公司的未来充满信心。我们一直希望看到内幕买盘,但值得注意的是,这些收购是否远低于今天的股价,因为随着价格的上涨,价值折扣可能已经缩小。在这种情况下,我们很高兴地向大家报告,内幕收购是以接近当前价格进行的。

In the last twelve months PetMed Express insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

在过去的十二个月中,PetMed Express内部人士在买入股票,但没有卖出股票。你可以在下面看到过去 12 个月内幕交易(由公司和个人进行的)的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
NasdaqGS:PETS Insider Trading Volume November 15th 2023
纳斯达克股票代码:PETS 内幕交易量 2023 年 11 月 15 日

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

内部人士总是会买入很多股票。因此,如果这适合你的风格,你可以逐一查看每只股票,也可以看看这份免费的公司名单。(提示:业内人士一直在购买它们)。

Insider Ownership Of PetMed Express

PetMed Express 的内部

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. From our data, it seems that PetMed Express insiders own 4.8% of the company, worth about US$7.4m. We do generally prefer see higher levels of insider ownership.

对于普通股股东来说,值得检查一下公司内部人士持有多少股票。我认为,如果内部人士拥有该公司的大量股份,那将是一个好兆头。从我们的数据来看,PetMed Express内部人士似乎拥有该公司4.8%的股份,价值约740万美元。我们通常更愿意看到更高的内部所有权水平。

So What Do The PetMed Express Insider Transactions Indicate?

那么 PetMed Express 内幕交易表明了什么?

It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that PetMed Express insiders are reasonably well aligned, and optimistic for the future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. While conducting our analysis, we found that PetMed Express has 1 warning sign and it would be unwise to ignore it.

看到最近的内幕收购无疑是积极的。对去年交易的分析也给了我们信心。但是,我们对公司亏损的事实有不同的看法。尽管内部人所有权的总体水平低于我们希望看到的水平,但交易历史表明,PetMed Express内部人士相当一致,对未来持乐观态度。因此,这些内幕交易可以帮助我们建立有关该股的论点,但了解该公司面临的风险也值得一试。在进行分析时,我们发现PetMed Express有1个警告信号,忽视它是不明智的。

Of course PetMed Express may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,PetMed Express可能不是最值得买入的股票。因此,您可能希望看到这些免费的高质量公司集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发